| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Nalidixate measurement (procedure) |
Component |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nalidixic acid adverse reaction |
Causative agent (attribute) |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to nalidixic acid |
Causative agent (attribute) |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nalidixic acid 60 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nalidixic acid+sodium citrate 660mg/sachet effervescent granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nalidixic acid 300mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nalidixic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nalidixic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nalidixic acid 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nalidixic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing disodium citrate and nalidixic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nalidixic acid adverse reaction (disorder) |
Causative agent (attribute) |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nalidixic acid sensitivity |
Causative agent (attribute) |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to nalidixic acid |
Causative agent (attribute) |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nalidixic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nalidixic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nalidixic acid 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nalidixic acid 1 g oral tablet |
Has basis of strength substance (attribute) |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nalidixic acid 1 g oral tablet |
Has precise active ingredient |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nalidixic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nalidixic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nalidixic acid 60 mg/mL oral suspension |
Has precise active ingredient |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nalidixic acid 60 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Citric acid- and nalidixic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only citric acid and nalidixic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only nalidixic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only nalidixic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nalidixic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely nalidixic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hypersensitivity to nalidixic acid (finding) |
Causative agent (attribute) |
True |
Nalidixic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]